Technology Offerings

TRPC6 Channel Blocker: A New Hope for Pulmonary and Renal Health

Written by admin-innovation

The invention comprises diterpene derivatives for the treatment of pulmonary hypertension in conjunction with respiratory disorders, especially asthma and COPD. The pharmacological effect is mediated by selective block of TRPC6, a member of the subfamily of canonical transient receptor potential channels.

Further Information: PDF

GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120

Contact
Beate-Victoria Ermisch

Comments (0)

Write a comment